Rabbit Recombinant Monoclonal ME3 antibody. Suitable for WB, IHC-P and reacts with Mouse, Rat, Human samples. Cited in 12 publications.
View Alternative Names
NADP-ME, Malic enzyme 3, ME3
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ME3 antibody [EPR10378] (AB172972)
Immunohistochemical analysis of paraffin-embedded Human brain tissue labeling ME3 with unpurified ab172972 at 1/50 dilution.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ME3 antibody [EPR10378] (AB172972)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human colon tissue sections labeling ME3 with Purified ab172972 at 1 : 200 dilution. Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use) secondary antibody was used at 1 : 0 dilution. PBS instead of the primary antibody was used as the negative control.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ME3 antibody [EPR10378] (AB172972)
Immunohistochemical analysis of paraffin-embedded Human thyroid gland carcinoma tissue labeling ME3 with unpurified ab172972 at 1/50 dilution.
- WB
Lab
Western blot - Anti-ME3 antibody [EPR10378] (AB172972)
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-ME3 antibody [EPR10378] (ab172972) at 1/5000 dilution
Lane 1:
Human fetal kidney lysates at 20 µg
Lane 2:
Mouse heart lysates at 20 µg
Lane 3:
Rat heart lysates at 20 µg
Lane 4:
Mouse brain lysates at 20 µg
Lane 5:
Rat brain lysates at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 67 kDa
Observed band size: 67 kDa
false
- WB
Supplier Data
Western blot - Anti-ME3 antibody [EPR10378] (AB172972)
All lanes:
Western blot - Anti-ME3 antibody [EPR10378] (ab172972) at 1/1000 dilution
Lane 1:
Fetal brain lysate at 10 µg
Lane 2:
Fetal kidney lysate at 10 µg
Lane 3:
Fetal heart lysate at 10 µg
Lane 4:
HeLa cell lysate at 10 µg
Predicted band size: 67 kDa
false
Related conjugates and formulations (1)
-
Anti-ME3 antibody [EPR10378] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ME3 influences cellular redox balance via its production of NADPH an important reducing agent. It is not part of a larger protein complex but serves an essential function on its own. ME3 contributes to lipid biosynthesis by supplying NADPH for fatty acid elongation and cholesterol synthesis which supports cell growth and proliferation. Its activity impacts overall metabolic homeostasis.
Pathways
ME3 has a significant role in the tricarboxylic acid (TCA) cycle and lipid metabolism. It interfaces with the TCA cycle by providing a critical link between carbohydrate and lipid metabolism through pyruvate production. ME3 interacts with other metabolic enzymes like citrate synthase emphasizing its integrating function in energy production and storage pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (12)
Recent publications for all applications. Explore the full list and refine your search
Biochimica et biophysica acta. Bioenergetics 1864:148930 PubMed36272463
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature cardiovascular research 1:817-829 PubMed36776621
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 82:435-446.e7 PubMed34847359
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cells 10: PubMed34199502
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell metabolism 33:1027-1041.e8 PubMed33770508
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 13: PubMed33375130
2020
Applications
Unspecified application
Species
Unspecified reactive species
Neoplasma 66:896-907 PubMed31607129
2019
Applications
Unspecified application
Species
Unspecified reactive species
iScience 13:229-242 PubMed30870781
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cancer research 78:1972-1985 PubMed29654155
2018
Applications
Unspecified application
Species
Unspecified reactive species
Nature 542:119-123 PubMed28099419
2017
Applications
WB
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com